Pay in 4 interest-free payments of $45.62 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Wogonin suppresses the LPS enhanced invasiveness of MDA MB 231 breast cancer cells by inhibiting the 5 LO/BLT2 cascade
Smiles: CC1=CC=C(C=C1N1C(=O)C(Br)=C(C=C1C)OCC1=CC=C(F)C=C1F)C(=O)NCCCCC1=CN(CCCC(=O)NCCCCNC2=CC=CC3=C2C(=O)N(C2CCC(=O)NC2=O)C3=O)N=N1
PubMed PMID: 24856675
and pancreatic cancer
Thalidomide D4 - CAS# 1219177-18-0 R40 Activator 1 Wogonin suppresses the LPS enhancedThalidomide D4 is a deuterium labeled Thalidomide. Thalidomide is initially promoted as a sedative, inhibits cereblon (CRBN), a part of the cullin 4 E3 ubiquitin ligase complex CUL4 RBX1 DDB1, with a Kd of ~250 nM, and has immunomodulatory, anti inflammatory and anti angiogenic cancer properties. Product information CAS Number: 1219177 18 0 Molecular Weight: 262. 25 Formula: C13H10N2O4 Chemical Name: 2 (2, 6 dioxopiperidin 3 yl) 2, 3 dihydro(H) 1H
US$ 36.00
US$ 23.00
US$ 60.00
US$ 58.00
US$ 29.00
US$ 36.00
US$ 35.00